
Progyny Inc
NASDAQ:PGNY

Net Margin
Progyny Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
Progyny Inc
NASDAQ:PGNY
|
1.9B USD |
4%
|
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
282.7B USD |
5%
|
|
US |
A
|
Anthem Inc
LSE:0HG8
|
97.9B USD |
3%
|
|
US |
![]() |
Elevance Health Inc
NYSE:ELV
|
86.1B USD |
3%
|
|
US |
![]() |
Humana Inc
NYSE:HUM
|
29.2B USD |
1%
|
|
US |
![]() |
Centene Corp
NYSE:CNC
|
26.9B USD |
2%
|
|
US |
![]() |
Molina Healthcare Inc
NYSE:MOH
|
16B USD |
3%
|
|
US |
![]() |
Healthequity Inc
NASDAQ:HQY
|
9.1B USD |
10%
|
|
BR |
![]() |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
17.9B BRL |
-3%
|
|
US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR |
6%
|
|
US |
![]() |
Clover Health Investments Corp
NASDAQ:CLOV
|
1.4B USD |
-2%
|
Progyny Inc
Glance View
In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Progyny Inc's most recent financial statements, the company has Net Margin of 4.3%.